← FDA Drug Approvals (Drugs@FDA)

DACARBAZINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HOSPIRA · Approved 2001-10-18

Drug application

FDA Application #

ANDA075940

Application type

Abbreviated New Drug Application (Generic)

Brand name

DACARBAZINE

Generic name

Dacarbazine

Active ingredients

DACARBAZINE

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Discontinued

Sponsor

HOSPIRA

First approval

2001-10-18

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown